A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy
Clinical Trial Information
Trial Contact: Parrimon, Yozandra; Tilme, Linda; Ross, Michelle
IRB No: 16.092.07
Principal Investigator: Devendra I Mehta, MD
Sub Investigators: Bornstein, Jeffrey MD; Horvath, Karoly MD; Jackson, Teri ARNP; Safder, Shaista MD; Raijer, Carolina, ARNP; Smadi, Yamen MD
Phase: Drug: Phase III
Age Group: Pediatric
Secondary Protocol No: BLI800-502
Applicable Disease Sites: Bowel Preparation, GI, colonoscopy
Therapies Involved: BLI800; NuLYTELY
ClinicalTrials.gov ID: NCT02819323
To compare the safety, tolerance and efficacy of BLI800 to NuLYTELY as bowel preparations prior to colonoscopy in adolescent patients 12 to 16 years.
1. Male or female between the ages of 12 to 16 years old.
2. Undergoing colonoscopy for routinely accepted indications.